HeartFlow Inc. reported adjusted earnings per share for the second quarter of 2026 that exceeded analyst expectations, prompting a 17% jump in its shares on Tuesday.
The company’s Q2 2026 EPS came in above the consensus estimate, according to a transcript of its earnings call. Financial details, including revenue and operating metrics, were not disclosed in the call transcript. HeartFlow’s stock surged following the news, reflecting investor confidence in the company’s financial performance.
Analysts had projected HeartFlow’s adjusted EPS for the quarter, though specific estimates were not provided in the available materials. The company’s focus on medical imaging technology, particularly in cardiovascular diagnostics, has been a key driver of investor interest in recent periods.
HeartFlow did not immediately respond to requests for additional financial data or guidance. The company’s next scheduled earnings update is expected in the coming months, pending regulatory filings and investor communications.
